Hostname: page-component-857557d7f7-8wkb5 Total loading time: 0 Render date: 2025-11-21T23:12:08.392Z Has data issue: false hasContentIssue false
  • English
  • Français

Prescribing Conventional Antipsychotics at Two Veterans Administration Hospitals: Are There Geographical Differences?

Published online by Cambridge University Press:  07 November 2014

Prakash S. Masand ,
Monica Arora ,
Thomas L. Schwartz ,
Anil Sharma ,
Xiaohong Wang ,
Subhash Bhatia ,
Jacob Manjooran ,
William Hardoby ,
Subhdeep Virk  and
Daniel J. Kuhles
...Show all authors
Get access Rights & Permissions [Opens in a new window]

Abstract

The medical records of 110 patients receiving conventional antipsychotics at two geographically distinct Veterans Administration hospitals (Syracuse, New York and Omaha, Nebraska) were reviewed. The most common reasons for continuation of conventional antipsychotics were good response and patient or physician choice. Frequently, physicians did not discuss the reasons for continuing conventional antipsychotics or the availability of alternative therapies with their patients. Geographic differences in physicians' prescribing practices of conventional antipsychotics were apparent.

Information

Type
Original Research
Information
CNS Spectrums , Volume 6 , Issue 11: Investigating and Treating Psychosis , November 2001 , pp. 894 - 896
Copyright
Copyright © Cambridge University Press 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

REFERENCES

1. Blin, O.A comparative review of new antipsychotics. Can J Psychiatry. 1999;44:235–244.CrossRefGoogle ScholarPubMed
2. Masand, PS, Berry, SL. Switching antipsychotic therapies. Ann Pharmacother. 2000;34:200–207.CrossRefGoogle ScholarPubMed
3. Expert Consensus Guidelines on the Treatment of Schizophrenia. J Clin Psychiatry. 1999;60(suppl 11):1–80.Google Scholar
4. American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia. Am J Psychiatry. 1997;154 (suppl 4):1–63.CrossRefGoogle Scholar
5. Gurian, BS, Baker, EH, Jacobson, S, Lagerbom, B, Watts, P. Informed consent for neuroleptics with elderly patients in two settings. J Am Geriatr Soc. 1990;38:37–44.CrossRefGoogle ScholarPubMed
6. Schachter, D, Kleinman, I. Psychiatrists' documentation of informed consent. Can J Psychiatry. 1998:43:1012–1017.CrossRefGoogle ScholarPubMed
7. Schachter, D, Kleinman, I, Williams, JI. Informed consent for antipsychotic medication: do family physicians document obtaining it? Can Fam Physician. 1999:45:1502–1508.Google Scholar
8. Marder, S. New treatments for schizophrenia. Presented at: 152nd Meeting of the American Psychiatric Association; May, 1999; Washington, DC.Google Scholar
9. Weiden, PJ, Aquila, R, Emanuel, M, Zygmunt, A. Long-term considerations after switching antipsychotics. J Clin Psychiatry. 1998;59(suppl 19):36–49.Google ScholarPubMed